Integrated Diagnostics

Integrated Diagnostics creates large-scale, blood-based molecular diagnostics that leverage advances in proteomics and genomics to detect disease at its earliest stage. The company was co-founded by Dr. Lee Hood in 2009 to develop diagnostics and measurement technologies capable of monitoring hundreds of biomarkers simultaneously, for earlier detection and more accurate management of complex diseases like lung cancer and Alzheimer’s disease.

Diagnostics development at Integrated Diagnostics is conceptually based on a systems biology view of disease – one where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules. By aiming to understand the whole system – and make sense out of a wealth of new genomics and proteomic information – Integrated Diagnostics creates diagnostics capable of detecting disease earlier, with greater precision.